Why peptide myths spread so easily
Peptides sit in an awkward space: some are FDA-approved medicines, some are compounded by pharmacies, some are under review, and many are sold online as research chemicals. Marketing tends to lump them together, either as effortless shortcuts or as dangerous steroids. Neither picture holds up.
The four myths below are the ones men raise most often at a first peptide therapy consultation. For each, we check the claim against the FDA’s current position and the human evidence for the peptides on our menu.
Myth 1: Peptides are just steroids by another name
They are different kinds of molecules that work in different ways. A peptide is a short chain of amino acids, the same building blocks as proteins. Anabolic steroids are synthetic versions of testosterone, built on a ring-shaped cholesterol backbone, and they act directly on androgen receptors throughout the body.
Most of the peptides men ask about act as signals rather than hormones. Sermorelin and tesamorelin prompt the pituitary gland to release more of your own growth hormone. BPC-157 and TB-500 are studied for tissue repair. None of them is testosterone. Our answer on whether peptides are the same as steroids goes further, and our comparison of peptides and SARMs covers another category that often gets mixed in.
That said, “not a steroid” does not mean “harmless” or “allowed in sport.” The World Anti-Doping Agency prohibits BPC-157 and TB-500 as well as growth hormone releasing factors.
Myth 2: A peptide will build muscle without the work
No peptide on our menu has good human evidence for building muscle on its own. The growth hormone peptides raise growth hormone and IGF-1, which sounds like a muscle story, but the trials measured other things.
Tesamorelin is the clearest example. In its main NEJM trial, 412 people with HIV and excess abdominal fat, 86% of them men, took daily tesamorelin or placebo for 26 weeks. Visceral fat fell 15.2% with tesamorelin and rose 5.0% with placebo, and IGF-1 rose 81%. That is a meaningful fat result in a specific group, not proof of muscle growth in healthy men. The label even notes the drug is not for weight loss because its effect on weight is neutral.
For sermorelin, the human data are older and smaller. It raises growth hormone and IGF-1 in many people, which your provider tracks with IGF-1 testing on sermorelin or tesamorelin, but the muscle you keep or build still comes from training, protein and sleep.
Myth 3: Peptides are all illegal, or all legal
Neither. Their legal status varies peptide by peptide, and it changed several times in 2025 and 2026.
| Peptide | FDA status as of October 2026 | Human evidence |
|---|---|---|
| Tesamorelin | FDA-approved as Egrifta (2010) for excess abdominal fat in HIV-associated lipodystrophy; other uses off-label; a biologic, so not compoundable | Randomized trials in that population |
| Sermorelin | Formerly approved as Geref; compounded today | Older, small studies on growth hormone and IGF-1 |
| NAD+ | Widely available as an injection and IV | Limited controlled human data for injected NAD+ |
| BPC-157 | Off FDA Category 2 since April 2026; recommended for the 503A list in July 2026; no final rule | FDA found no or only limited safety information |
| TB-500 | Same as BPC-157 | FDA identified no human exposure data |
| GHK-Cu | Off Category 2 since April 2026; review due by early 2027 | FDA cited limited human data for injectable use |
The tesamorelin label is the most solid footing on the list. The evidence notes for BPC-157, TB-500 and GHK-Cu come straight from the FDA’s Category 2 page, which now lists them as nominated but withdrawn. Leaving that list does not make them eligible for compounding; our article on the FDA’s 2026 peptide decisions explains what is still pending.
Some peptides sold online, such as CJC-1295, ipamorelin and AOD-9604, are not eligible for compounding in the United States, so they are not on our menu at all. State pharmacy rules add another layer, which our answer on whether peptides are legal in California walks through.
Myth 4: If it is natural, it must be safe
Many peptides are copies or fragments of molecules the body makes, which leads people to assume they are gentle. The FDA’s review notes tell a more careful story. For several peptides, it flagged the risk of immune reactions, where the body treats an injected peptide as foreign, and the difficulty of measuring impurities created during manufacturing.
Where a peptide comes from matters as much as which one it is. A licensed compounding pharmacy works under pharmacy quality rules, while a product labeled “for research use only” has no such checks. Common, mostly mild side effects at injection sites, such as redness or itching, are worth knowing about too; the tesamorelin and sermorelin pages list what to expect from each.
What peptides can reasonably do
Stripped of the myths, the picture is narrower and more useful. Tesamorelin has trial evidence for reducing visceral fat in a specific group. Sermorelin can raise your own growth hormone output, measured by IGF-1. NAD+ is widely used, with modest evidence so far. The recovery peptides have strong anecdotal demand and thin human data, plus an unsettled legal path.
None of them replaces training, sleep, nutrition or treatment of an underlying condition such as low testosterone. Results, where they come, tend to take weeks to months; our answer on how long peptides take to work gives realistic timelines.
How Ultimate Male decides whether a peptide fits
Every peptide plan at our San Gabriel and Downey clinics starts with blood work, including IGF-1, metabolic and hormone markers, and a one-on-one consultation about your goals. When a peptide makes sense, it is supplied by a licensed U.S. compounding pharmacy or, for tesamorelin, as the approved medicine, and you get follow-up labs at six to eight weeks.
If the honest answer is that no peptide fits your goal, or that something else explains your symptoms, you will hear that too. The free 10-minute call is the place to ask about a specific peptide’s status before you book.
